Amir Anbiyaiee, Shirin Azizidoost, Maryam Farzaneh
{"title":"Therapeutic Potential of MSC-conditioned Medium: A Multifactorial\nApproach to Enhance Wound Healing","authors":"Amir Anbiyaiee, Shirin Azizidoost, Maryam Farzaneh","doi":"10.2174/0115743624266715240202104221","DOIUrl":null,"url":null,"abstract":"\n\nWound healing is a highly intricate process that involves a coordinated interplay of\nvarious cellular and molecular events. In recent years, mesenchymal stem cells (MSCs) have\ngarnered significant attention as a promising therapeutic modality due to their remarkable regenerative properties. In addition to their capacity for direct tissue repair and differentiation,\nMSCs release a diverse repertoire of bioactive factors into the surrounding microenvironment,\ncollectively termed an MSC-conditioned Medium (MSC-CM). This review aims to elucidate the\ntherapeutic potential of MSC-CM as a multifactorial approach to enhance wound healing. MSCCM encompasses an extensive range of factors, including growth factors, cytokines, chemokines, extracellular matrix proteins, and non-coding RNAs, which collectively orchestrate and\nstimulate multiple cellular processes crucial for effective wound healing. Notably, these factors\nplay pivotal roles in promoting angiogenesis, stimulating the proliferation and migration of various cell types involved in wound repair, modulating the immune response, and facilitating extracellular matrix remodeling. Moreover, compelling evidence from preclinical and clinical\nstudies demonstrates that MSC-CM administration accelerates wound closure, enhances reepithelialization, and improves the quality of granulation tissue. By harnessing the therapeutic\npotential of MSC-CM, we can pave the way for significant advancements in wound care, ultimately leading to improved patient outcomes.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"239 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624266715240202104221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Wound healing is a highly intricate process that involves a coordinated interplay of
various cellular and molecular events. In recent years, mesenchymal stem cells (MSCs) have
garnered significant attention as a promising therapeutic modality due to their remarkable regenerative properties. In addition to their capacity for direct tissue repair and differentiation,
MSCs release a diverse repertoire of bioactive factors into the surrounding microenvironment,
collectively termed an MSC-conditioned Medium (MSC-CM). This review aims to elucidate the
therapeutic potential of MSC-CM as a multifactorial approach to enhance wound healing. MSCCM encompasses an extensive range of factors, including growth factors, cytokines, chemokines, extracellular matrix proteins, and non-coding RNAs, which collectively orchestrate and
stimulate multiple cellular processes crucial for effective wound healing. Notably, these factors
play pivotal roles in promoting angiogenesis, stimulating the proliferation and migration of various cell types involved in wound repair, modulating the immune response, and facilitating extracellular matrix remodeling. Moreover, compelling evidence from preclinical and clinical
studies demonstrates that MSC-CM administration accelerates wound closure, enhances reepithelialization, and improves the quality of granulation tissue. By harnessing the therapeutic
potential of MSC-CM, we can pave the way for significant advancements in wound care, ultimately leading to improved patient outcomes.
期刊介绍:
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.